1,118 results on '"Wu, Chin-Lee"'
Search Results
102. Data from Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer
103. Supplementary Methods from miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer
104. Supplementary Figure 1 legend from Branched Chain RNA In Situ Hybridization for Androgen Receptor Splice Variant AR-V7 as a Prognostic Biomarker for Metastatic Castration-Sensitive Prostate Cancer
105. Supplementary Data from Molecular Characterization of Neuroendocrine-like Bladder Cancer
106. Figure S5 from GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate
107. Data from Cystatin B As a Tissue and Urinary Biomarker of Bladder Cancer Recurrence and Disease Progression
108. Table S1 from GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate
109. Supplementary Tab S1-S9 from miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer
110. Supplementary Figure 1 from Branched Chain RNA In Situ Hybridization for Androgen Receptor Splice Variant AR-V7 as a Prognostic Biomarker for Metastatic Castration-Sensitive Prostate Cancer
111. Data from GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate
112. Fig s1-s8 from Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer
113. Supplementary Figures from Molecular Characterization of Neuroendocrine-like Bladder Cancer
114. Supplementary Fig. S1-S9 from miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer
115. Supplementary Data from Cystatin B As a Tissue and Urinary Biomarker of Bladder Cancer Recurrence and Disease Progression
116. Supplementary information from GPD1 Enhances the Anticancer Effects of Metformin by Synergistically Increasing Total Cellular Glycerol-3-Phosphate
117. Supplementary Figure Legends 1-6 from Identification of the ENT1 Antagonists Dipyridamole and Dilazep as Amplifiers of Oncolytic Herpes Simplex Virus-1 Replication
118. Supplementary Figures 1-6 from Identification of the ENT1 Antagonists Dipyridamole and Dilazep as Amplifiers of Oncolytic Herpes Simplex Virus-1 Replication
119. Supplementary Materials and Methods from Identification of the ENT1 Antagonists Dipyridamole and Dilazep as Amplifiers of Oncolytic Herpes Simplex Virus-1 Replication
120. Data from β1 Integrin Cytoplasmic Variants Differentially Regulate Expression of the Antiangiogenic Extracellular Matrix Protein Thrombospondin 1
121. Data from Identification of the ENT1 Antagonists Dipyridamole and Dilazep as Amplifiers of Oncolytic Herpes Simplex Virus-1 Replication
122. Supplementary Figure Legend from β1 Integrin Cytoplasmic Variants Differentially Regulate Expression of the Antiangiogenic Extracellular Matrix Protein Thrombospondin 1
123. Supplementary Figure 1 from β1 Integrin Cytoplasmic Variants Differentially Regulate Expression of the Antiangiogenic Extracellular Matrix Protein Thrombospondin 1
124. Abstract IA010: Hypomethylation of immune-related loci contribute to prostate tumorigenesis
125. Mucosa-sparing, KTP Laser Coagulation of Submucosal Telangiectatic Vessels in Patients With Radiation-induced Cystitis: A Novel Approach
126. Differentiating progressive from nonprogressive T1 bladder cancer by gene expression profiling: Applying RNA-sequencing analysis on archived specimens
127. TSC2 inactivation, low mutation burden and high macrophage infiltration characterise hepatic angiomyolipomas.
128. CIRBP is a novel oncogene in human bladder cancer inducing expression of HIF-1α
129. Increased expression of immediate early response gene 3 protein promotes aggressive progression and predicts poor prognosis in human bladder cancer
130. Editorial: The application of artificial intelligence in diagnosis, treatment and prognosis in urologic oncology
131. The Clinical Significance of the Positive Surgical Margin and Dominant Tumor Laterality Following Radical Prostatectomy: A Retrospective Study
132. NCOA5 Haploinsufficiency Results in Glucose Intolerance and Subsequent Hepatocellular Carcinoma
133. Peutz-Jeghers syndrome: a critical look at colonic Peutz-Jeghers polyps
134. Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial
135. Development and validation of a 32-gene prognostic index for prostate cancer progression
136. Androgenic to oestrogenic switch in the human adult prostate gland is regulated by epigenetic silencing of steroid 5α‐reductase 2
137. Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome
138. A Close Surgical Margin After Radical Prostatectomy is an Independent Predictor of Recurrence
139. Viral proteins and virus-like particles of the LTR5_Hs endogenous retrovirus in human primordial germ cell-like cells
140. Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network
141. A new transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma
142. Identification of a novel microRNA-mRNA regulatory biomodule in human prostate cancer
143. RETRACTED ARTICLE: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer
144. Downregulation of TRPM7 suppressed migration and invasion by regulating epithelial–mesenchymal transition in prostate cancer cells
145. mTOR and HIF-1α-Mediated Tumor Metabolism in an LKB1 Mouse Model of Peutz-Jeghers Syndrome
146. Men With Organ-confined Prostate Cancer and Positive Surgical Margins Develop Biochemical Failure at a Similar Rate to Men With Extracapsular Extension
147. Abstract 982: A new transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma
148. Abstract 2510: An atlas of single-cell and spatial transcriptomics reveals alterations that correlate with human prostate cancer progression
149. Abstract 2322: Multiplatform metabolomics studies of human cancers with NMR and mass spectrometry imaging
150. Abstract 2222: Detecting clinically significant prostate cancers: Tissue metabolomics refines multiparametric MRI-ultrasound fusion prostate biopsy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.